◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

China Traditional Chinese Medicine Holdings Co. Limited (0570) Financial History

Name: China Traditional Chinese Medicine Holdings Co. Limited (0570) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

China Traditional Chinese Medicine Holdings Co. Limited (0570) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 14,846 employees. Its market capitalization is roughly CNY 7 billion. In the fiscal year ended 2025-12-31, 0570 reported CNY 14.7B in revenue and (CNY 342M) in net income.

China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of traditional Chinese medicine (TCM) and pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

Interactive charts & full statements →

0570 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	CNY 14.7B	CNY 16.5B	CNY 18.1B	CNY 14.3B
Gross Profit	CNY 7.1B	CNY 7.9B	CNY 9.3B	CNY 7.2B
Operating Income (EBIT)	CNY 621M	CNY 924M	CNY 1.4B	CNY 1.2B
Net Income	(CNY 342M)	CNY 54M	CNY 1.3B	CNY 764M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0570 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 396M)	—	(CNY 240M)	(CNY 314M)	(CNY 276M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0570 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 32.3B	CNY 35.1B	CNY 37.1B	CNY 35.6B	—
Total Liabilities	CNY 9.3B	CNY 11.1B	CNY 13.1B	CNY 12.7B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0570 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

4512 · Wakamoto Pharmaceutical Co.,Ltd. — $9 billion
2186 · Luye Pharma Group Ltd. — $8 billion
0460 · Sihuan Pharmaceutical Holdings Group Ltd. — $8 billion
APTX · Apotex Health Corp. — $8 billion
2005 · SSY Group Limited — $7 billion
2575 · Xuanzhu Biopharmaceutical Co., Ltd. — $6 billion
6185 · CanSino Biologics Inc. — $6 billion
4539 · Nippon Chemiphar Co., Ltd. — $6 billion

← 0568 All “0-9” companies 0571 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.